Stocks and Investing Stocks and Investing
Mon, October 11, 2021
Sun, October 10, 2021
Fri, October 8, 2021
Thu, October 7, 2021
Wed, October 6, 2021
Tue, October 5, 2021

Christopher Raymond Maintained (BHVN) at Buy with Increased Target to $156 on, Oct 5th, 2021


Published on 2024-10-27 18:03:36 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "Biohaven Ltd." (BHVN) at Buy with Increased Target from $140 to $156 on, Oct 5th, 2021.

Christopher has made no other calls on BHVN in the last 4 months.



There are 6 other peers that have a rating on BHVN. Out of the 6 peers that are also analyzing BHVN, 2 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Esther Rajavelu of "UBS" Downgraded from Strong Buy to Hold and Increased Target to $109 on, Tuesday, August 10th, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $107 on, Friday, July 16th, 2021


These are the ratings of the 4 analyists that currently disagree with Christopher


  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $165 on, Monday, September 13th, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $150 on, Tuesday, August 3rd, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $134 on, Monday, July 12th, 2021
  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $135 on, Thursday, July 8th, 2021